These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26834751)

  • 1. Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells.
    König M; Rharbaoui F; Aigner S; Dälken B; Schüttrumpf J
    Front Immunol; 2016; 7():11. PubMed ID: 26834751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway.
    Helling B; König M; Dälken B; Engling A; Krömer W; Heim K; Wallmeier H; Haas J; Wildemann B; Fritz B; Jonuleit H; Kubach J; Dingermann T; Radeke HH; Osterroth F; Uherek C; Czeloth N; Schüttrumpf J
    Immunol Cell Biol; 2015 Apr; 93(4):396-405. PubMed ID: 25512343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High thioredoxin-1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody Tregalizumab.
    Heim K; Dälken B; Faust S; Rharbaoui F; Engling A; Wallmeier H; Dingermann T; Radeke HH; Schüttrumpf J; Gutscher M
    Clin Transl Immunology; 2016 Dec; 5(12):e121. PubMed ID: 28090323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients.
    Barberá A; Lorenzo N; Garrido G; Mazola Y; Falcón V; Torres AM; Hernández MI; Hernández MV; Margry B; de Groot AM; van Roon J; van der Zee R; Broere F; van Eden W; Padrón G; Domínguez Mdel C
    Int Immunopharmacol; 2013 Dec; 17(4):1075-83. PubMed ID: 24177275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.
    Bayry J; Sibéril S; Triebel F; Tough DF; Kaveri SV
    Drug Discov Today; 2007 Jul; 12(13-14):548-52. PubMed ID: 17631249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis.
    van Amelsfort JM; van Roon JA; Noordegraaf M; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2007 Mar; 56(3):732-42. PubMed ID: 17328044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
    Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
    J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
    Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
    J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis.
    Nistala K; Wedderburn LR
    Rheumatology (Oxford); 2009 Jun; 48(6):602-6. PubMed ID: 19269955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tregalizumab (BT-061) increases regulatory T cell function. Boosting regulatory T-cell function with the humanized CD4-specific humanized monoclonal antibody Tregalizumab (BT-061).
    Humblet-Baron S; Baron F
    Immunol Cell Biol; 2015 Apr; 93(4):321-2. PubMed ID: 25666094
    [No Abstract]   [Full Text] [Related]  

  • 11. Number and phenotype of rheumatoid arthritis patients' CD4+CD25hi regulatory T cells are not affected by adalimumab or etanercept.
    Blache C; Lequerré T; Roucheux A; Beutheu S; Dedreux I; Jacquot S; Le Loët X; Boyer O; Vittecoq O
    Rheumatology (Oxford); 2011 Oct; 50(10):1814-22. PubMed ID: 21791546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased apoptosis induction in CD4+ CD25+ Foxp3+ T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation.
    Li N; Ma T; Han J; Zhou J; Wang J; Zhang J; Zheng S
    Eur Rev Med Pharmacol Sci; 2014; 18(1):78-85. PubMed ID: 24452947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of radiolabeled anti-CD4 antibodies in the diagnosis of rheumatoid arthritis.
    Kinne RW; Emmrich F; Freesmeyer M
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):629-38. PubMed ID: 21221070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells in Arthritis.
    Komatsu N; Takayanagi H
    Prog Mol Biol Transl Sci; 2015; 136():207-15. PubMed ID: 26615098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells.
    Benito-Miguel M; García-Carmona Y; Balsa A; Pérez de Ayala C; Cobo-Ibáñez T; Martín-Mola E; Miranda-Carús ME
    J Immunol; 2009 Dec; 183(12):8268-79. PubMed ID: 20007590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
    Kikuchi J; Hashizume M; Kaneko Y; Yoshimoto K; Nishina N; Takeuchi T
    Arthritis Res Ther; 2015 Jan; 17(1):10. PubMed ID: 25604867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
    Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
    Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyfunctional, Pathogenic CD161+ Th17 Lineage Cells Are Resistant to Regulatory T Cell-Mediated Suppression in the Context of Autoimmunity.
    Basdeo SA; Moran B; Cluxton D; Canavan M; McCormick J; Connolly M; Orr C; Mills KH; Veale DJ; Fearon U; Fletcher JM
    J Immunol; 2015 Jul; 195(2):528-40. PubMed ID: 26062995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.